Status:
COMPLETED
Transcutaneous Electrical Stimulation for Spasticity in Patients With Primary Lateral Sclerosis
Lead Sponsor:
Nova Southeastern University
Conditions:
Primary Lateral Sclerosis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine if non-invasive electrical stimulation, using an electric stimulator placed on the skin of the patients back and abdomen for 30 minutes can reduce muscl...
Detailed Description
Objective: The primary aim of this preliminary pilot study is to assess the clinical effects of transcutaneous electrical stimulation (tES) in reducing spasticity in the lower extremities and increasi...
Eligibility Criteria
Inclusion
- Diagnosis of primary lateral sclerosis by the treating neurologist
- Ambulatory with or without a assistive device or orthotic
Exclusion
- History of cancer in the lumbar or thoracic spine
- History of surgery with hardware in the lumbar or thoracic spine
- Acute lower back pathology
- Current pregnancy
- History of implantable cardiac device
- Diagnosis of significant cognitive impairment by the treating physician
- History of seizures or diagnosis of epilepsy
- Open wound at location of electrodes
- Complete loss of sensation at the area of electrode placement
Key Trial Info
Start Date :
August 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2024
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT06012110
Start Date
August 28 2023
End Date
August 22 2024
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NSU Health Neuroscience Institute
Davie, Florida, United States, 33328